Phreesia (NYSE:PHR) General Counsel Sells $67,152.96 in Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison Hoffman sold 6,662 shares of Phreesia stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $10.08, for a total value of $67,152.96. Following the sale, the general counsel directly owned 266,574 shares in the company, valued at approximately $2,687,065.92. This trade represents a 2.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Phreesia Stock Performance

Phreesia stock traded up $0.07 during trading hours on Tuesday, hitting $10.11. The stock had a trading volume of 476,751 shares, compared to its average volume of 1,449,417. The company has a 50-day moving average of $11.15 and a two-hundred day moving average of $10.32. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.33. Phreesia, Inc. has a fifty-two week low of $7.77 and a fifty-two week high of $25.00. The company has a market cap of $627.22 million, a PE ratio of 59.44 and a beta of 0.86.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Wednesday, September 2nd. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.06). The firm had revenue of $129.46 million for the quarter, compared to analyst estimates of $129.06 million. Phreesia had a return on equity of 5.22% and a net margin of 2.06%.Phreesia’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.01 EPS. On average, equities research analysts anticipate that Phreesia, Inc. will post 0.33 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on PHR. Wall Street Zen lowered shares of Phreesia from a “buy” rating to a “hold” rating in a report on Saturday, September 5th. Truist Financial raised their price objective on shares of Phreesia from $11.00 to $12.00 and gave the stock a “hold” rating in a report on Thursday, May 28th. Needham & Company LLC reiterated a “buy” rating and set a $14.00 target price on shares of Phreesia in a research report on Monday, August 31st. Royal Bank Of Canada reissued an “outperform” rating and issued a $19.00 target price on shares of Phreesia in a research note on Thursday, September 3rd. Finally, Weiss Ratings lowered shares of Phreesia from a “sell (d+)” rating to a “sell (d)” rating in a research report on Friday, September 4th. Eight analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $14.00.

Institutional Trading of Phreesia

Hedge funds have recently modified their holdings of the company. Pale Fire Capital SE raised its holdings in Phreesia by 3.2% during the 2nd quarter. Pale Fire Capital SE now owns 8,924,329 shares of the company’s stock worth $91,831,000 after purchasing an additional 275,000 shares during the last quarter. BlackRock Inc. bought a new position in shares of Phreesia in the 2nd quarter valued at about $72,234,000. Granahan Investment Management LLC grew its position in shares of Phreesia by 73.8% during the 4th quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock worth $40,601,000 after buying an additional 1,018,987 shares during the period. Bank of America Corp DE grew its position in shares of Phreesia by 142.6% during the 1st quarter. Bank of America Corp DE now owns 1,001,057 shares of the company’s stock worth $8,389,000 after buying an additional 588,444 shares during the period. Finally, Meros Investment Management LP raised its stake in shares of Phreesia by 48.5% during the fourth quarter. Meros Investment Management LP now owns 478,274 shares of the company’s stock worth $8,092,000 after buying an additional 156,137 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc is a healthcare technology company that provides software and services designed to help healthcare organizations manage patient intake and engagement. Its platform digitizes administrative and clinical processes that traditionally rely on paper forms, manual data entry, and separate payment systems.

The company’s offerings include digital patient check-in and registration, insurance and demographic information collection, appointment-related communications, electronic forms and consent management, patient surveys, and payment processing.